Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Down syndrome and Alzheimer's

Topic: Genetics and APOE

Plain-language summary

Amyloid plaques contain numerous proteins in addition to amyloid beta in Alzheimer’s disease (AD). Previous localized proteomics identified plaque-associated proteins in late-onset AD, early-onset AD, rapidly progressive AD, preclinical AD, and AD in Down syndrome, although most studies had smaller cohorts and focused primarily on severe pathology. The amyloid plaque proteome in mild cognitive impairment (MCI) has not been evaluated. We evaluated plaque proteomes in MCI and AD with comparisons to neighboring non-plaque tissue and control non-plaque tissue from ROSMAP (151 cases (n = 240 samples); control (n = 62), MCI (n = 36), AD (n = 53)). Tissue was microdissected from autopsy paraffin embedded temporal cortex and evaluated by label-free quantitative proteomics. We identified differentially abundant proteins with robust differences at a false discovery rate (FDR) < 5% and fold-change > 1.5 for 135 proteins in MCI and 156 in AD plaque tissue compared to neighboring non-plaque tissue, which included proteins described previously as well as novel proteins. Gene ontology (GO) term associations included increased inflammatory response and lysosome proteins in both MCI and AD, and decreased myelin proteins particularly in AD. Of plaque proteins altered in at least one disease group, many changed in the same fold-change direction (p < 0.0001, R 2 = 0.53) and there were 100 shared proteins in MCI and AD. In non-plaque tissue, there were 277 differentially abundant proteins in MCI and 177 in AD; associated with structural constituent of chromatin in MCI and negative regulation of DNA recombination and autolysosome in AD, with decreased proteins associated with actin-myosin filament in AD. Weighted gene correlation network analysis (WGCNA) identified proteins associated with pathology and demographics. We have conducted the most extensive proteomics of microdissected plaque proteomes in both MCI and AD. Our results provide insights into MCI and AD molecular mechanisms, novel biomarkers, and potential novel therapeutic targets.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Leitner, D., Kanshin, E., Balcomb, K., Askenazi, M., Suazo, J., Marta-Ariza, M., et al. (2026). The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment. Research Square. https://doi.org/10.21203/rs.3.rs-9012095/v1

Vancouver

Leitner D, Kanshin E, Balcomb K, Askenazi M, Suazo J, Marta-Ariza M, et al. The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment. Research Square. 2026. doi:10.21203/rs.3.rs-9012095/v1.

BibTeX

@article{leitner2026-e4a188be,
  author  = {Leitner, D. and Kanshin, E. and Balcomb, K. and Askenazi, M. and Suazo, J. and Marta-Ariza, M. and schneider, J. and Ueberheide, B. and others},
  title   = {{The Amyloid Plaque Proteomes of Alzheimer’s Disease and Mild Cognitive Impairment}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-9012095/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-9012095/v1}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 18 of the 62 points it could be judged on, which is 29 of 100. Raw total 29 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 29 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 29 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 18 of the 62 points we could judge it on, which is 29 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (Research Square)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 240 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 18 / 62 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 18 of the 62 points we could judge it on is 29 out of 100.
Total 29 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Down syndrome and Alzheimer's from nearby years

Also tagged “single-nucleus”

274 studies in the library carry the topic tag “single-nucleus”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 274 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →